Walleye Capital
MRTX

Walleye Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Walleye Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,413
Closed -$1.43M – 6143
2023
Q4 		$1.43M Buy
+24,413
New +$1.37M ﹤0.01% 2055
2023
Q3 		– Sell
-39,564
Closed -$1.43M – 5476
2023
Q2 		$1.43M Sell
39,564
-142,916
-78% -$5.89M 0.01% 1557
2023
Q1 		$6.78M Buy
182,480
+140,382
+333% +$6.31M 0.1% 237
2022
Q4 		$1.91M Buy
+42,098
New +$2.72M 0.03% 614
2022
Q2 		– Sell
-2,691
Closed -$221K – 2789
2022
Q1 		$221K Sell
2,691
-18,405
-87% -$1.88M 0.01% 1460
2021
Q4 		$3.1M Buy
+21,096
New +$3.28M 0.1% 230
2020
Q1 		– Sell
-4,462
Closed -$575K – 1847
2019
Q4 		$575K Buy
+4,462
New +$430K 0.04% 616
2019
Q3 		– Sell
-820
Closed -$84K – 2346
2019
Q2 		$84K Buy
+820
New +$63.8K 0.01% 1270

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's MRTX Position: Q1 2024 in Review

Walleye Capital sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 24,413 shares — an estimated $1.43M sold.

Walleye Capital first reported a position in MRTX in Q2 2019 and held it in 8 quarters. The position peaked at $6.78M in Q1 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Walleye Capital reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 24,413 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.43M.
  • Walleye Capital first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Walleye Capital's Mirati Therapeutics, Inc. Common Stock position peaked at $6.78M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.